Chemoinformaics analysis of nor-ketoagarofuran
Molecular Weight | 235.239 | nRot | 1 |
Heavy Atom Molecular Weight | 222.135 | nRig | 12 |
Exact Molecular Weight | 235.084 | nRing | 2 |
Solubility: LogS | -3.316 | nHRing | 1 |
Solubility: LogP | 1.63 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 33.0163 |
nHD | 1 | BPOL | 18.8197 |
QED | 0.805 |
Synth | 2.642 |
Natural Product Likeliness | 0.852 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.01 |
Pgp-sub | 0.001 |
HIA | 0.068 |
CACO-2 | -4.611 |
MDCK | 0.0000418 |
BBB | 0.988 |
PPB | 0.778783 |
VDSS | 0.624 |
FU | 0.252374 |
CYP1A2-inh | 0.933 |
CYP1A2-sub | 0.647 |
CYP2c19-inh | 0.456 |
CYP2c19-sub | 0.697 |
CYP2c9-inh | 0.29 |
CYP2c9-sub | 0.796 |
CYP2d6-inh | 0.022 |
CYP2d6-sub | 0.569 |
CYP3a4-inh | 0.046 |
CYP3a4-sub | 0.279 |
CL | 6.691 |
T12 | 0.785 |
hERG | 0.012 |
Ames | 0.392 |
ROA | 0.975 |
SkinSen | 0.193 |
Carcinogencity | 0.496 |
EI | 0.014 |
Respiratory | 0.399 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.569552 |